[Percutaneous radiofrequency ablation in treatment of advanced local lung cancer: clinical analysis of 78 cases].
Zi Lin Huang, Pei Hong Wu, Ming Zhao, Wang Li, Wei Jun Fan, Fu Jun Zhang, Jin Huang, Yang Gu
Abstract
Zi Lin Huang, Pei Hong Wu, Ming Zhao, Wang Li, Wei Jun Fan, Fu Jun Zhang, Jin Huang, Yang Gu
Abstract
OBJECTIVE: To investigate the efficacy and safety of radiofrequency ablation (RFA) in treatment of advanced lung cancer. METHODS: Seventy-eight patients with advanced local lung cancer were treated with RFA at the temperature from 70 degrees C to 90 degrees C under local or intravenous anesthesia under CT scan for 8 minutes to 26 minutes. 103 times of RFA were done in 78 patients, 19 of them being treated twice and 2 treated tree times. Followed up was conducted for 1 - 6 months. The outcomes were evaluated by plain and contrast spiral CT scanning. RESULTS: During RFA 32 patients felt pain, and 18 patients experienced cough and hemoptysis. After RFA pneumothorax was seen in 18 of the patients, and contrast spiral CT scanning showed devascularization and/or reduction of tumor size in 67 lesions. CONCLUSION: Removing tumor load rapidly and with excellent short-term outcome, percutaneous RAF is safe to treat advanced local lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the efficacy and safety of radiofrequency ablation (RFA) in treatment of advanced lung cancer. METHODS: Seventy-eight patients with advanced local lung cancer were treated with RFA at the temperature from 70 degrees C to 90 degrees C under local or intravenous anesthesia under CT scan for 8 minutes to 26 minutes. 103 times of RFA were done in 78 patients, 19 of them being treated twice and 2 treated tree times. Followed up was conducted for 1 - 6 months. The outcomes were evaluated by plain and contrast spiral CT scanning. RESULTS: During RFA 32 patients felt pain, and 18 patients experienced cough and hemoptysis. After RFA pneumothorax was seen in 18 of the patients, and contrast spiral CT scanning showed devascularization and/or reduction of tumor size in 67 lesions. CONCLUSION: Removing tumor load rapidly and with excellent short-term outcome, percutaneous RAF is safe to treat advanced local lung cancer.
Key concepts: Medicine, Radiofrequency ablation, Percutaneous, Pneumothorax, Lung cancer, Radiology, Ablation, Surgery